Much effort has been put forth to study the mechanistic role of IL‐6 in PCa, supporting that IL‐6 is a key cancer‐promoting factor and rational therapeutic target (Lee et al., 2003; Qu et al., 2013; Zhong et al., 2016). Here, IL6 is linked to posterior cortical atrophy.